Sierra - International Biopharmaceutical Industry

Current Edition

news

GSK acquires Sierra Oncology, betting $2B on a bone cancer drug with a long history

GlaxoSmithKline has agreed to acquire Sierra Oncology for $1.9 billion in a bet that an experimental drug the small biotech developed is on the cusp of becoming a val...

14 April 2022 news cancer | Drug

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

GSK acquires Sierra Oncology, betting $2B on a bone cancer drug with a long history

International Biopharmaceutical Industry